Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

DIASOL INC

Subsidiary ofDIASOL INCUEI: KHK6KV388KF5CAGE: 67L88

DIASOL INC is a federal contractor, registered under UEI KHK6KV388KF5 and CAGE code 67L88. It has been awarded $1,706,878 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Electromedical and Electrotherapeutic Apparatus Manufacturing, and Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Justice and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

KHK6KV388KF5

CAGE Code

67L88

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationSubchapter S CorporationWoman-Owned BusinessWomen-Owned Small BusinessManufacturer of Goods

NAICS Codes

325411Medicinal and Botanical Manufacturing
325412Pharmaceutical Preparation Manufacturing(Primary)
339113Surgical Appliance and Supplies Manufacturing

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Diasol Inc. specializes in the manufacturing and supply of electromedical and electrophysiological apparatus, with a focused expertise in acid-bicarbonate delivery systems critical to renal dialysis and critical care applications. The company’s technical capabilities center on precision formulation,...

Diasol Inc. specializes in the manufacturing and supply of electromedical and electrophysiological apparatus, with a focused expertise in acid-bicarbonate delivery systems critical to renal dialysis and critical care applications. The company’s technical capabilities center on precision formulation, sterile compounding, and regulatory-compliant production of therapeutic solutions used in federal medical facilities. Their products support life-sustaining treatments under stringent quality controls, demonstrating deep familiarity with FDA-regulated medical device and pharmaceutical manufacturing standards. Key differentiators include consistent on-time delivery of time-sensitive clinical supplies and the ability to meet complex federal procurement requirements for chronic care programs. Diasol Inc. maintains a sustained, high-frequency relationship with the Department of Justice, supplying specialized acid-bicarbonate formulations for the U.S. Medical Center for Federal Prisoners. Their contract history reflects a mission-critical role in sustaining dialysis programs across federal correctional healthcare facilities, with recurring awards indicating long-term operational dependency on their supply chain reliability and regulatory adherence. The company’s primary industry focus is in NAICS 334510—electromedical and electrophysiological apparatus manufacturing—where it serves the niche but vital segment of renal therapy delivery systems. This vertical specialization positions Diasol as a trusted provider within federal correctional and institutional healthcare markets, where consistent access to sterile, FDA-compliant dialysis solutions is non-negotiable. Diasol Inc. is a Women-Owned Small Business headquartered in Phoenix, Arizona, with a structure designed for agile federal contracting. Its certifications as a Woman-Owned Small Business and Woman-Owned Business enhance its eligibility for set-aside opportunities and reflect a commitment to diversity in federal supply chains. The company’s geographic presence supports national distribution networks, enabling reliable logistics to federal medical facilities across the United States.

Key Performance Metrics

Awards Count

133

All time

Active

0

Currently performing

Completed

133

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with DIASOL INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DIASOL INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DIASOL INC's top NAICS codes and agencies

NAICS: 334510
New
Federal
Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection
Solicitation # BARDA-FY27-10192026
The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.
Barda - Aspr / Daappo / Barda Dcma

POSTED

about 6 hours ago

DEADLINE

in 29 days
View Details